Showing results (251-260 of 34,619) with videos related to
Sort By:
Pageof 3,462
Cancer|April 2, 2011
Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapyAllan Lipton, Kim Leitzel, Suhail M Ali, et al.Cancer|April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemiaMeir Wetzler, Chris Andrews, Laurie A Ford, et al.Cancer|April 15, 2011
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagyMin-Yu Chen, Warren S-L Liao, Zhen Lu, et al.Cancer|December 1, 1990
Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifeneR Valavaara, J Tuominen, R JohanssonCancer|April 8, 2011
Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectivesHun J Lee, James E Thompson, Eunice S Wang, et al.Cancer|April 8, 2011
Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancerJeffrey M Albert, Ana M Gonzalez-Angulo, Merih Guray, et al.Cancer|April 8, 2011
The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesCarey K Anders, Allison M Deal, C Ryan Miller, et al.Cancer|April 8, 2011
Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID useN Jewel Samadder, Bhramar Mukherjee, Shu-Chen Huang, et al.Cancer|April 8, 2011
Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanomaThomas K Eigentler, Adina Figl, Dietmar Krex, et al.Cancer|April 8, 2011
Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter studyKazuya Motomura, Atsushi Natsume, Yugo Kishida, et al.Pageof 3,462